Home
Home

lixisenatide

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Yahoo

Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA

Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA
Yahoo/Global NewsWire

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
Yahoo/MarketWire

News

Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg

News

Sanofi Lixisenatide Diabetes Treatment Had Significant Phase Three Results
Bloomberg
»

News

It'll Be a Blockbuster! High Fives All Around, Right?
Motley Fool
»

News

Sanofi-Aventis diabetes drug meets study endpoints
Marketwatch
»